National Health Investors Financial Statements
NYSE: NHIReal EstateReal Estate Investment TrustsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
National Health Investors revenue and earnings
In fiscal 2025, National Health Investors generated $375.6 million in revenue, up 12.1% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $142.2 million (+3.0% year over year), for a net margin of 37.9% versus a median of 41.2% in the prior 5 years. Diluted earnings per share came in at $3.02, down from $3.13.
Over the last 5 fiscal years, NHI's revenue has grown at a 2.5% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
National Health Investors income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 375.63M | 335.18M | 319.83M | 278.19M | 298.71M | 332.81M | 318.08M | 294.61M | 278.66M | 248.46M |
| Revenue growth (YoY) | +12.07% | +4.80% | +14.97% | -6.87% | -10.24% | +4.63% | +7.97% | +5.72% | +12.15% | +8.52% |
| Operating Expenses | 238.96M | 211.88M | 200.88M | 241.86M | 216.14M | 161.77M | 156.81M | 139.54M | 127.17M | 129.69M |
| Interest Expense | 57.37M | 59.90M | 58.16M | 44.92M | 50.81M | 52.88M | 56.30M | 49.05M | 46.32M | 43.11M |
| Other Income (Expense) | 0 | 0 | 202.00K | 0 | 350.00K | 0 | 0 | 0 | 10.09M | 35.91M |
| Pretax Income | — | — | — | — | — | — | 161.27M | 155.07M | 151.49M | 118.77M |
| Income Tax | — | — | — | — | — | — | — | 138.00K | 124.00K | 854.00K |
| Net Income | 142.18M | 137.99M | 135.65M | 66.40M | 111.80M | 185.13M | 160.46M | 154.33M | 159.37M | 151.54M |
| Net Income growth (YoY) | +3.04% | +1.72% | +104.29% | -40.61% | -39.61% | +15.37% | +3.97% | -3.16% | +5.16% | +1.80% |
| EPS (Basic) | 3.03 | 3.14 | 3.13 | 1.48 | 2.45 | 4.14 | 3.70 | 3.68 | 3.90 | 3.88 |
| EPS (Diluted) | 3.02 | 3.13 | 3.13 | 1.48 | 2.44 | 4.14 | 3.67 | 3.67 | 3.87 | 3.87 |
| Shares Outstanding (Basic) | 46.87M | 43.84M | 43.39M | 44.77M | 45.71M | 44.70M | 43.42M | 41.94M | 40.89M | 39.01M |
| Shares Outstanding (Diluted) | 47.05M | 44.10M | 43.39M | 44.79M | 45.73M | 44.70M | 43.70M | 42.09M | 41.15M | 39.16M |
| Net Margin | 37.85% | 41.17% | 42.41% | 23.87% | 37.43% | 55.62% | 50.45% | 52.39% | 57.19% | 60.99% |
This table shows 10 annual periods of National Health Investors's income statement, from FY 2025 back to FY 2016, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow NHI's reporting calendar. What is a income statement?